dapagliflozin
Diabetes
Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to insufficient insulin production or reduced insulin sensitivity. There are two types of diabetes: type 1 and type 2. The diabetes treatment is complicated because the glucose level may be slightly reduced and be controlled, but it is impossible to cure of the disease.
In recent years, new medications have been developed to help manage this condition more effectively. One such drug is dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor primarily used to treat type 2 diabetes. Dapagliflozin blocks glucose reabsorption in the kidneys promotes excretion through urine, and lowers blood sugar levels. This innovative mechanism of action offers an additional treatment option for individuals with diabetes, often in combination with other medications such as metformin or insulin. When used as part of a comprehensive diabetes management plan, which includes a healthy diet, regular exercise, and blood sugar monitoring, dapagliflozin can contribute to improved glycemic control and overall health for individuals living with type 2 diabetes.
Subscribe to our free newsletter